Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
GlobalData estimates that the global pancreatitis therapeutics market was worth $36m in 2011 and forecasts it to grow at a Compound Annual Growth Rate (CAGR) of 3.6% to $47.7m by 2019. The current treatment options for pancreatitis offer only symptomatic relief and are primarily generic. There are no currently approved disease-modifying drugs in the market and only one in the pipeline (somatostatin). As a result, the market is expected to show slow growth until 2019.
View full press release